Cumberland Pharmaceuticals (NASDAQ:CPIX) Releases Quarterly Earnings Results

Key Points

• Cumberland Pharmaceuticals reported earnings of $0.02 per share for the quarter, with a negative net margin of 7.98% and a positive return on equity of 6.92%.
• The company's stock has declined by 5.5%, currently trading at $3.79, compared to its 50-day moving average of $4.15.
• Analysts upgraded Cumberland Pharmaceuticals from a "buy" rating to a "strong-buy" rating, indicating increased investor confidence.

Cumberland Pharmaceuticals (NASDAQ:CPIX - Get Free Report) issued its earnings results on Tuesday. The specialty pharmaceutical company reported $0.02 EPS for the quarter, Zacks reports. Cumberland Pharmaceuticals had a negative net margin of 6.97% and a positive return on equity of 7.68%.

Cumberland Pharmaceuticals Price Performance

Shares of NASDAQ:CPIX traded down $0.05 during midday trading on Friday, reaching $3.23. The company's stock had a trading volume of 104,385 shares, compared to its average volume of 84,492. The business's fifty day simple moving average is $3.99 and its 200-day simple moving average is $4.42. The company has a market capitalization of $48.32 million, a P/E ratio of -14.68 and a beta of -0.39. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.25 and a quick ratio of 1.09. Cumberland Pharmaceuticals has a fifty-two week low of $1.04 and a fifty-two week high of $7.25.

Wall Street Analyst Weigh In

Separately, Wall Street Zen downgraded shares of Cumberland Pharmaceuticals from a "strong-buy" rating to a "buy" rating in a report on Saturday.

Cumberland Pharmaceuticals Company Profile

Cumberland Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.